In Re: National Prescription Opiate Litigation

Track this case

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. August 06, 2019

    Opioid MDL Judge Signals Support For 'Negotiation Class'

    An Ohio federal judge on Tuesday appeared likely to approve provocative plans to broker settlements in the multidistrict opioid litigation by using a first-of-its-kind "negotiation class" potentially consisting of every city and county in the U.S.

  2. August 05, 2019

    Timetable For Opioid MDL Trial 'Entirely Untenable': Drug Cos.

    Drug companies in the multidistrict opioid litigation on Monday lambasted the seven-week timeline for the first bellwether trial, deeming it "entirely untenable" and an affront to due process in the sprawling case.

  3. July 22, 2019

    Unlawful Pain Pill Sales Undeniable, Opioid MDL Counties Say

    Seeking a leg up in an upcoming bellwether trial, Ohio counties in the multidistrict opioid litigation are asserting that drug companies sold highly addictive painkillers with such clear disregard for illicit use that they can't credibly deny violating federal law.

  4. July 16, 2019

    Judge OKs Release Of National Opioid Sales Data

    The Ohio federal judge overseeing multidistrict litigation over the opioid crisis said that national data on opioid sales before December 2012 should be publicly available.

  5. July 16, 2019

    Pharmacy Benefit Cos. Improved Opioid Policies, Judge Says

    The nation's biggest pharmacy benefit management companies have voluntarily implemented policies to help clamp down on painkiller prescriptions, according to an Ohio federal judge overseeing multidistrict litigation over the opioid addiction epidemic.

  6. July 12, 2019

    Native American Cases To Watch In 2nd Half Of 2019

    Native American law practitioners will be keeping close tabs on the U.S. Supreme Court's reboot of a murder case with major implications for tribal jurisdiction in Oklahoma as well as on Fifth Circuit challenges to the Indian Child Welfare Act and the Affordable Care Act and the first trial in the massive opioid multidistrict litigation.

  7. July 03, 2019

    Product Liability Cases To Watch: Midyear Review

    For the rest of 2019, product liability attorneys will be closely following Oklahoma's case alleging Johnson & Johnson fueled the opioid epidemic and the litigation Boeing is facing after two fatal crashes involving its 737 Max 8 aircraft. Here, Law360 looks at those and other cases to watch in the second half of 2019.

  8. July 03, 2019

    The Biggest Legal Ethics Decisions Of 2019: Midyear Report

    During the first six months of 2019, the legal ethics arena saw a Tenth Circuit decision on judicial ethics complaints against U.S. Supreme Court Justice Brett Kavanaugh and the first of several potential rulings on conflicts in the “Varsity Blues” college admissions case. Here are some of the top legal ethics and malpractice decisions from the first half of the year.

  9. July 01, 2019

    Opioid MDL Litigants Seek Triumphs Before Bellwether Trial

    As a bellwether trial nears in multidistrict opioid litigation, drug companies and Ohio local governments are seeking victories on crucial legal questions over liability for a deadly addiction epidemic and a proposed multibillion-dollar remedy.

  10. June 25, 2019

    Opioid MDL Judge Seems Open To Novel Deal Approach

    The Ohio federal judge overseeing the opioid multidistrict litigation appeared receptive Tuesday to an inventive proposal to create a class of local governments to negotiate a global settlement with drug companies accused of fueling the addiction crisis, saying novel problems need novel solutions.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!